518 related articles for article (PubMed ID: 18375007)
1. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Murata R; Tsujitani M; Horsman MR
Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
[TBL] [Abstract][Full Text] [Related]
2. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Horsman MR; Overgaard J
Radiother Oncol; 2004 Mar; 70(3):301-9. PubMed ID: 15064017
[TBL] [Abstract][Full Text] [Related]
3. Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
Murata R; Horsman MR
Int J Hyperthermia; 2004 Jun; 20(4):393-404. PubMed ID: 15204520
[TBL] [Abstract][Full Text] [Related]
4. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
Horsman MR; Nielsen T; Østergaard L; Overgaard J
Acta Oncol; 2006; 45(7):876-80. PubMed ID: 16982553
[TBL] [Abstract][Full Text] [Related]
5. Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin.
Overgaard J; Khan AR
Cancer Treat Rep; 1981; 65(5-6):501-3. PubMed ID: 7195305
[TBL] [Abstract][Full Text] [Related]
6. Effect of increase of radiation dose on local control relates to pre-treatment FDG uptake in FaDu tumours in nude mice.
Schütze C; Bergmann R; Yaromina A; Hessel F; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B
Radiother Oncol; 2007 Jun; 83(3):311-5. PubMed ID: 17502117
[TBL] [Abstract][Full Text] [Related]
7. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
[TBL] [Abstract][Full Text] [Related]
8. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
9. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.
Schreiber A; Krause M; Zips D; Dörfler A; Richter K; Vettermann S; Petersen C; Beuthien-Baumann B; Thümmler D; Baumann M
Strahlenther Onkol; 2004 Jun; 180(6):375-82. PubMed ID: 15175873
[TBL] [Abstract][Full Text] [Related]
10. Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo.
Molin J; Søgaard PE; Overgaard J
Cancer Treat Rep; 1981; 65(7-8):583-9. PubMed ID: 6166372
[TBL] [Abstract][Full Text] [Related]
11. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells.
Horsman MR; Chaplin DJ; Overgaard J
Cancer Res; 1990 Dec; 50(23):7430-6. PubMed ID: 2147577
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
Ohizumi Y; Lam GK; Pickles T; Fryer C; Chaplin DJ
Radiat Med; 1995; 13(6):291-5. PubMed ID: 8850370
[TBL] [Abstract][Full Text] [Related]
13. Residual damage in mouse lungs at long intervals after cyclophosphamide treatment.
Travis EL; Bucci L; Fang MZ
Cancer Res; 1990 Apr; 50(7):2139-45. PubMed ID: 2317805
[TBL] [Abstract][Full Text] [Related]
14. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
Petersen C; Zips D; Krause M; Völkel W; Thames HD; Baumann M
Radiother Oncol; 2005 Mar; 74(3):331-6. PubMed ID: 15763315
[TBL] [Abstract][Full Text] [Related]
15. The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
Hokland SL; Horsman MR
Int J Hyperthermia; 2007 Nov; 23(7):599-606. PubMed ID: 18038290
[TBL] [Abstract][Full Text] [Related]
16. Oxygen cathode measurements and radiation response in tumour-bearing mice treated with misonidazole.
Davies RW; Hall WS
Br J Cancer Suppl; 1978 Jun; 3():154-8. PubMed ID: 277216
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of local tumour control by misonidazole and hyperthermia.
Stone HB
Br J Cancer Suppl; 1978 Jun; 3():178-83. PubMed ID: 277222
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
Kirichenko AV; Rich TA; Newman RA; Travis EL
Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients.
Nielsen T; Murata R; Maxwell RJ; Stødkilde-Jørgensen H; Ostergaard L; Horsman MR
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):859-66. PubMed ID: 18164835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]